1. Pharmaxis
2. Home
3. Investors
4. Corporate Directory

Corporate Directory

The Pharmaxis Corporate Directory provides details and contact information of our:

• Directors
• Company Secretary and Chief Financial Officer
• Investor Relations and Media Enquiries
• Registered Office
• Securities Exchange Listings
• Legal Advisors
• Auditor
• Bankers
• Patent Attorney
• Share Registry
• American Depositary Receipts

Directors

Denis Hanley - Chairman
Alan Robertson - CEO
Will Delaat
Malcolm McComas
Richard van den Broek
John Villiger

Company Secretary and Chief Financial Officer

David McGarvey

Investor Relations and Media Enquiries

David McGarvey

Media Enquiries

Felicity Moffatt

Registered Office

20 Rodborough Road
Frenchs Forest NSW 2086
Australia
Telephone: +61 2 9454 7200
Fax: +61 2 9451 3622
Email: info@pharmaxis.com.au
Website: www.pharmaxis.com.au

Securities Exchange Listings

Pharmaxis shares are listed on the Australian Stock Exchange (Code: PXS)
Pharmaxis American Depositary Receipts are traded on the U.S. over-the-counter market (Code: PXSLY)

Legal Advisors

PFM Legal Pty Ltd
Level 12,
117 York Street,
Sydney NSW 2000
Australia
Venable LLP
575 7^th Street, NW
Washington, DC 20004
United States of America

Auditor

PricewaterhouseCoopers
Darling Park Tower 2
201 Sussex Street
Sydney NSW 2000
Australia

Bankers

HSBC Bank Australia Ltd Westpac Banking Corporation

Share Registry

Computershare Investor Services Pty Ltd
Level 3, 60 Carrington Street
Sydney NSW 2000
Australia
Telephone: 1300 855 080
Fax: +61 3 9473 2500
Website: www.computershare.com Shareholders can access information and services relevant to their holding from the Pharmaxis website under Investor Information/Shareholder Services

American Depositary Receipts

BNY Mellon Shareowner Services
480 Washington Blvd., 27th floor
Jersey City, NJ 07310
Telephone within the U.S.: (201) 680-4000
Telephone outside the U.S.: +1 201 680 6825